Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.0%

3 terminated/withdrawn out of 25 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

12%

3 trials in Phase 3/4

Results Transparency

17%

3 of 18 completed trials have results

Key Signals

2 recruiting3 with results

Enrollment Performance

Analytics

N/A
19(82.6%)
Phase 4
3(13.0%)
Phase 2
1(4.3%)
23Total
N/A(19)
Phase 4(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials
NCT06593080Not ApplicableRecruiting

The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis

Role: collaborator

NCT03149627Completed

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

Role: collaborator

NCT05950919Not ApplicableRecruiting

Effects of a Package of Evidence-based Interventions and Implementation Strategies Based on WHO PEN for People Living With HIV and Cardio-metabolic Conditions in Lusaka, Zambia

Role: collaborator

NCT00949481Not ApplicableCompleted

Increasing Family Planning Uptake Among Postpartum Women

Role: collaborator

NCT06883643Not ApplicableCompleted

Adoption of Innovative Approaches to Ensure Continuity of Quality TB Services During COVID-19 Pandemic in Lusaka and Livingstone, Zambia. (Telemedicine in TB)

Role: collaborator

NCT04839900Not ApplicableCompleted

Proactive Community Case Management for Malaria in Zambia

Role: collaborator

NCT05005130Not ApplicableCompleted

Task-shifted Adaptation of the WHO-PEN Intervention to Address Cardio-metabolic Complications in People Living With HIV in Zambia

Role: collaborator

NCT04800055Not ApplicableUnknown

Attractive Targeted Sugar Bait Phase III Trial in Zambia

Role: collaborator

NCT02612896Not ApplicableCompleted

Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?

Role: collaborator

NCT04891250Phase 4Withdrawn

The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19

Role: collaborator

NCT02654912Phase 4Completed

Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration

Role: collaborator

NCT03101592Not ApplicableTerminated

INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV

Role: collaborator

NCT02329301Not ApplicableCompleted

Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia

Role: collaborator

NCT01241318Phase 2Completed

Zambia Chlorhexidine Application Trial

Role: collaborator

NCT02776254Not ApplicableCompleted

Differentiated Care for Improved Health Systems Efficiency and Health Outcomes in Zambia

Role: collaborator

NCT03263182Completed

Impact of the Safe Childbirth Checklist in Luapula Province of Zambia Province of Zambia

Role: collaborator

NCT02242565Not ApplicableCompleted

Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia

Role: collaborator

NCT03132285Not ApplicableCompleted

Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device

Role: lead

NCT02394522Not ApplicableWithdrawn

Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)

Role: collaborator

NCT02866097Not ApplicableUnknown

Integrated Community Case Management Study in Eastern Province, Zambia

Role: collaborator